These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28427954)

  • 1. Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program.
    Fedewa SA; Corley DA; Jensen CD; Zhao W; Goodman M; Jemal A; Ward KC; Levin TR; Doubeni CA
    Am J Prev Med; 2017 Sep; 53(3):335-344. PubMed ID: 28427954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of racial/ethnic colorectal cancer screening disparities.
    Jerant AF; Fenton JJ; Franks P
    Arch Intern Med; 2008 Jun; 168(12):1317-24. PubMed ID: 18574089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
    Liss DT; Baker DW
    Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems.
    Burnett-Hartman AN; Mehta SJ; Zheng Y; Ghai NR; McLerran DF; Chubak J; Quinn VP; Skinner CS; Corley DA; Inadomi JM; Doubeni CA;
    Am J Prev Med; 2016 Oct; 51(4):e107-15. PubMed ID: 27050413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death.
    Doubeni CA; Corley DA; Jensen CD; Levin TR; Ghai NR; Cannavale K; Zhao WK; Selby K; Buckner-Petty S; Zauber AG; Fletcher RH; Weiss NS; Schottinger JE
    JAMA Netw Open; 2024 Jul; 7(7):e2423671. PubMed ID: 39028667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Against colorectal cancer in our neighborhoods (ACCION): A comprehensive community-wide colorectal cancer screening intervention for the uninsured in a predominantly Hispanic community.
    Shokar NK; Byrd T; Salaiz R; Flores S; Chaparro M; Calderon-Mora J; Reininger B; Dwivedi A
    Prev Med; 2016 Oct; 91():273-280. PubMed ID: 27575314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
    Selby K; Jensen CD; Levin TR; Lee JK; Schottinger JE; Zhao WK; Corley DA; Doubeni CA
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):145-152. PubMed ID: 33010408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal Cancer Screening After Sequential Outreach Components in a Demographically Diverse Cohort.
    Podmore C; Selby K; Jensen CD; Zhao WK; Weiss NS; Levin TR; Schottinger J; Doubeni CA; Corley DA
    JAMA Netw Open; 2024 Apr; 7(4):e245295. PubMed ID: 38625704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey.
    Etzioni DA; Ponce NA; Babey SH; Spencer BA; Brown ER; Ko CY; Chawla N; Breen N; Klabunde CN
    Cancer; 2004 Dec; 101(11):2523-32. PubMed ID: 15505783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Multifaceted Outreach to Initiate Colorectal Cancer Screening in Community Health Centers: A Randomized Controlled Trial.
    Goldman SN; Liss DT; Brown T; Lee JY; Buchanan DR; Balsley K; Cesan A; Weil J; Garrity BH; Baker DW
    J Gen Intern Med; 2015 Aug; 30(8):1178-84. PubMed ID: 25814264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Screening and Race in an Equal Access Medical System.
    Haddad JD; You DM
    J Community Health; 2016 Feb; 41(1):78-81. PubMed ID: 26187092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program.
    Chiu HM; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Pan SL; Wu MS; Liao CS; Chen HH; Koong SL; Chiou ST
    Cancer; 2015 Sep; 121(18):3221-9. PubMed ID: 25995082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of patient-provider communication on colorectal cancer screening.
    Carcaise-Edinboro P; Bradley CJ
    Med Care; 2008 Jul; 46(7):738-45. PubMed ID: 18580394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study.
    Gordon NP; Green BB
    BMC Public Health; 2015 Jun; 15():546. PubMed ID: 26062732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.